Health Care & Life Sciences » Biotechnology | Keryx Biopharmaceuticals Inc.

Keryx Biopharmaceuticals Inc. | Ownership

Companies that own Keryx Biopharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Baupost Group LLC
25,791,678
21.41%
0
0.65%
06/30/2018
Abrams Capital Management LP
9,950,055
8.26%
230,879
0.86%
06/30/2018
The Vanguard Group, Inc.
7,816,813
6.49%
234,630
0%
06/30/2018
BlackRock Fund Advisors
6,055,807
5.03%
444,994
0%
06/30/2018
SSgA Funds Management, Inc.
4,114,687
3.42%
-1,013,536
0%
06/30/2018
Rice, Hall, James & Associates LLC
2,278,007
1.89%
361,533
0.26%
06/30/2018
Norges Bank Investment Management
2,051,898
1.7%
349,963
0%
12/31/2017
ClearBridge LLC
1,456,329
1.21%
-1,197,935
0.1%
06/30/2018
Northern Trust Investments, Inc.
1,197,419
0.99%
103,856
0%
06/30/2018
Morgan Stanley & Co. LLC
1,071,543
0.89%
767,981
0%
06/30/2018

About Keryx Biopharmaceuticals

View Profile
Address
12th Floor
Boston Massachusetts 02210
United States
Employees -
Website http://www.keryx.com
Updated 09/14/2018
Keryx Biopharmaceuticals, Inc. engages in the manufacture, development, and commercialization of medicines for use in treating human diseases. Its product is the Auryxia tablet. The company was founded in October 1998 and is headquartered in Boston, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.